Effect of transamniotic administration of epidermal growth factor on fetal rabbit small intestinal nutrient transport and disaccharidase development

Terry L. Buchmiller, Kenneth S. Shaw, H. Leon Chopourian, Kevin C K Lloyd, Jeffrey Gregg, Francisco A. Rivera, Mandy L. Lam, Jared M. Diamond, Eric W. Fonkalsrud

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

As fetal swallowing is documented in utero, supplementation of the ingested amniotic fluid with nutrients or hormones has been postulated as a potential prenatal treatment for intrauterine growth retardation (IUGR). To study the effect of epidermal growth factor (EGF) on the developing fetal small intestine, 12 pregnant rabbits underwent operation on day 24 of a normal 31-day gestation. Bilateral ovarian end fetuses underwent catheterization of their respective amniotic cavities with attachment to a miniosmotic pump. study fetuses received recombinant human EGF at ∼300 μg/kg/d for 1 week; controls received carrier solution only at an equivalent rate. On gestational day 31, fetuses were delivered by cesarean section and somatic measurements were recorded. The small intestine was harvested and proximal, middle, and distal regions were analyzed for lactase and maltase enzyme activity. Additionally, the uptake of radiolabeled glucose and proline was measured by a standard everted mucosal sleeve technique for each segment. Results were analyzed by Student's paired t test and reported as mean±SEM. Nine fetal pairs survived (75%). Small intestinal (SI) length was increased in EGF fetuses (54.8±1.9 cm) versus control (50.4±2.7 cm) (P=.02). Lactase activity, reported as UE/g protein, was significantly increased in the proximal segments in the EGF-infused fetuses; maltase was significantly increased in both the proximal and middle segments (P<.05). Nutrient transport of both glucose and proline demonstrated a trend to increase in all segments when analyzed per cm and per mg tissue, reaching significance in the proximal regions for both substrates (P<.05). This report provides the first description of the in situ effects of supplemental EGF administration on fetal rabbit small intestinal development. The inclusion of EGF in supplemental amniotic feeding solutions is supported.

Original languageEnglish (US)
Pages (from-to)1239-1244
Number of pages6
JournalJournal of Pediatric Surgery
Volume28
Issue number10
DOIs
StatePublished - 1993
Externally publishedYes

Fingerprint

Disaccharidases
Epidermal Growth Factor
Rabbits
Fetus
Food
Lactase
alpha-Glucosidases
Proline
Small Intestine
Glucose
Fetal Growth Retardation
Amniotic Fluid
Deglutition
Catheterization
Cesarean Section
Hormones
Students
Pregnancy
Enzymes

Keywords

  • epidermal growth factor (EGF)
  • fetal rabbit
  • Small intestinal development

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Surgery

Cite this

Effect of transamniotic administration of epidermal growth factor on fetal rabbit small intestinal nutrient transport and disaccharidase development. / Buchmiller, Terry L.; Shaw, Kenneth S.; Leon Chopourian, H.; Lloyd, Kevin C K; Gregg, Jeffrey; Rivera, Francisco A.; Lam, Mandy L.; Diamond, Jared M.; Fonkalsrud, Eric W.

In: Journal of Pediatric Surgery, Vol. 28, No. 10, 1993, p. 1239-1244.

Research output: Contribution to journalArticle

Buchmiller, Terry L. ; Shaw, Kenneth S. ; Leon Chopourian, H. ; Lloyd, Kevin C K ; Gregg, Jeffrey ; Rivera, Francisco A. ; Lam, Mandy L. ; Diamond, Jared M. ; Fonkalsrud, Eric W. / Effect of transamniotic administration of epidermal growth factor on fetal rabbit small intestinal nutrient transport and disaccharidase development. In: Journal of Pediatric Surgery. 1993 ; Vol. 28, No. 10. pp. 1239-1244.
@article{264ddcf7d11a43cabd10c27dc57ce423,
title = "Effect of transamniotic administration of epidermal growth factor on fetal rabbit small intestinal nutrient transport and disaccharidase development",
abstract = "As fetal swallowing is documented in utero, supplementation of the ingested amniotic fluid with nutrients or hormones has been postulated as a potential prenatal treatment for intrauterine growth retardation (IUGR). To study the effect of epidermal growth factor (EGF) on the developing fetal small intestine, 12 pregnant rabbits underwent operation on day 24 of a normal 31-day gestation. Bilateral ovarian end fetuses underwent catheterization of their respective amniotic cavities with attachment to a miniosmotic pump. study fetuses received recombinant human EGF at ∼300 μg/kg/d for 1 week; controls received carrier solution only at an equivalent rate. On gestational day 31, fetuses were delivered by cesarean section and somatic measurements were recorded. The small intestine was harvested and proximal, middle, and distal regions were analyzed for lactase and maltase enzyme activity. Additionally, the uptake of radiolabeled glucose and proline was measured by a standard everted mucosal sleeve technique for each segment. Results were analyzed by Student's paired t test and reported as mean±SEM. Nine fetal pairs survived (75{\%}). Small intestinal (SI) length was increased in EGF fetuses (54.8±1.9 cm) versus control (50.4±2.7 cm) (P=.02). Lactase activity, reported as UE/g protein, was significantly increased in the proximal segments in the EGF-infused fetuses; maltase was significantly increased in both the proximal and middle segments (P<.05). Nutrient transport of both glucose and proline demonstrated a trend to increase in all segments when analyzed per cm and per mg tissue, reaching significance in the proximal regions for both substrates (P<.05). This report provides the first description of the in situ effects of supplemental EGF administration on fetal rabbit small intestinal development. The inclusion of EGF in supplemental amniotic feeding solutions is supported.",
keywords = "epidermal growth factor (EGF), fetal rabbit, Small intestinal development",
author = "Buchmiller, {Terry L.} and Shaw, {Kenneth S.} and {Leon Chopourian}, H. and Lloyd, {Kevin C K} and Jeffrey Gregg and Rivera, {Francisco A.} and Lam, {Mandy L.} and Diamond, {Jared M.} and Fonkalsrud, {Eric W.}",
year = "1993",
doi = "10.1016/S0022-3468(05)80305-7",
language = "English (US)",
volume = "28",
pages = "1239--1244",
journal = "Journal of Pediatric Surgery",
issn = "0022-3468",
publisher = "W.B. Saunders Ltd",
number = "10",

}

TY - JOUR

T1 - Effect of transamniotic administration of epidermal growth factor on fetal rabbit small intestinal nutrient transport and disaccharidase development

AU - Buchmiller, Terry L.

AU - Shaw, Kenneth S.

AU - Leon Chopourian, H.

AU - Lloyd, Kevin C K

AU - Gregg, Jeffrey

AU - Rivera, Francisco A.

AU - Lam, Mandy L.

AU - Diamond, Jared M.

AU - Fonkalsrud, Eric W.

PY - 1993

Y1 - 1993

N2 - As fetal swallowing is documented in utero, supplementation of the ingested amniotic fluid with nutrients or hormones has been postulated as a potential prenatal treatment for intrauterine growth retardation (IUGR). To study the effect of epidermal growth factor (EGF) on the developing fetal small intestine, 12 pregnant rabbits underwent operation on day 24 of a normal 31-day gestation. Bilateral ovarian end fetuses underwent catheterization of their respective amniotic cavities with attachment to a miniosmotic pump. study fetuses received recombinant human EGF at ∼300 μg/kg/d for 1 week; controls received carrier solution only at an equivalent rate. On gestational day 31, fetuses were delivered by cesarean section and somatic measurements were recorded. The small intestine was harvested and proximal, middle, and distal regions were analyzed for lactase and maltase enzyme activity. Additionally, the uptake of radiolabeled glucose and proline was measured by a standard everted mucosal sleeve technique for each segment. Results were analyzed by Student's paired t test and reported as mean±SEM. Nine fetal pairs survived (75%). Small intestinal (SI) length was increased in EGF fetuses (54.8±1.9 cm) versus control (50.4±2.7 cm) (P=.02). Lactase activity, reported as UE/g protein, was significantly increased in the proximal segments in the EGF-infused fetuses; maltase was significantly increased in both the proximal and middle segments (P<.05). Nutrient transport of both glucose and proline demonstrated a trend to increase in all segments when analyzed per cm and per mg tissue, reaching significance in the proximal regions for both substrates (P<.05). This report provides the first description of the in situ effects of supplemental EGF administration on fetal rabbit small intestinal development. The inclusion of EGF in supplemental amniotic feeding solutions is supported.

AB - As fetal swallowing is documented in utero, supplementation of the ingested amniotic fluid with nutrients or hormones has been postulated as a potential prenatal treatment for intrauterine growth retardation (IUGR). To study the effect of epidermal growth factor (EGF) on the developing fetal small intestine, 12 pregnant rabbits underwent operation on day 24 of a normal 31-day gestation. Bilateral ovarian end fetuses underwent catheterization of their respective amniotic cavities with attachment to a miniosmotic pump. study fetuses received recombinant human EGF at ∼300 μg/kg/d for 1 week; controls received carrier solution only at an equivalent rate. On gestational day 31, fetuses were delivered by cesarean section and somatic measurements were recorded. The small intestine was harvested and proximal, middle, and distal regions were analyzed for lactase and maltase enzyme activity. Additionally, the uptake of radiolabeled glucose and proline was measured by a standard everted mucosal sleeve technique for each segment. Results were analyzed by Student's paired t test and reported as mean±SEM. Nine fetal pairs survived (75%). Small intestinal (SI) length was increased in EGF fetuses (54.8±1.9 cm) versus control (50.4±2.7 cm) (P=.02). Lactase activity, reported as UE/g protein, was significantly increased in the proximal segments in the EGF-infused fetuses; maltase was significantly increased in both the proximal and middle segments (P<.05). Nutrient transport of both glucose and proline demonstrated a trend to increase in all segments when analyzed per cm and per mg tissue, reaching significance in the proximal regions for both substrates (P<.05). This report provides the first description of the in situ effects of supplemental EGF administration on fetal rabbit small intestinal development. The inclusion of EGF in supplemental amniotic feeding solutions is supported.

KW - epidermal growth factor (EGF)

KW - fetal rabbit

KW - Small intestinal development

UR - http://www.scopus.com/inward/record.url?scp=0027429050&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027429050&partnerID=8YFLogxK

U2 - 10.1016/S0022-3468(05)80305-7

DO - 10.1016/S0022-3468(05)80305-7

M3 - Article

C2 - 8263680

AN - SCOPUS:0027429050

VL - 28

SP - 1239

EP - 1244

JO - Journal of Pediatric Surgery

JF - Journal of Pediatric Surgery

SN - 0022-3468

IS - 10

ER -